Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (121-130 of 302) with videos related to

Pageof 31
Sort By:
Cancer Causes & Control : CCC|September 3, 2017
Cardiovascular disease mortality among women with endometrial cancer in the Iowa Women's Health StudyAshley S Felix, Cindy K Blair, Amy Lehman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group studyBradley J Monk, Michael W Sill, D Scott McMeekin, et al.
Cancer Biology & Therapy|July 15, 2016
Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancerAdam C ElNaggar, Uksha Saini, Shan Naidu, et al.
Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.
Gynecologic Oncology|September 27, 2014
Comprehensive evaluation of caspase-14 in vulvar neoplasia: an opportunity for treatment with black raspberry extractAmy S Joehlin-Price, Camille T Elkins, Julie A Stephens, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Gynecologic Oncology|March 5, 2017
The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendationsDavid E Cohn, Emily Ko, Larissa A Meyer, et al.
Gynecologic Oncology|June 30, 2009
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, David M O'Malley, et al.
Gynecologic Oncology|September 8, 2007
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterusAaron H Wolfson, Mark F Brady, Thomas Rocereto, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2015
Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative ComplicationsFloor J Backes, Maggie Rosen, Margaret Liang, et al.
Pageof 31

Showing results (121-130 of 302) with videos related to

Sort By:
Pageof 31
Cancer Causes & Control : CCC|September 3, 2017
Cardiovascular disease mortality among women with endometrial cancer in the Iowa Women's Health StudyAshley S Felix, Cindy K Blair, Amy Lehman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group studyBradley J Monk, Michael W Sill, D Scott McMeekin, et al.
Cancer Biology & Therapy|July 15, 2016
Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancerAdam C ElNaggar, Uksha Saini, Shan Naidu, et al.
Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.
Gynecologic Oncology|September 27, 2014
Comprehensive evaluation of caspase-14 in vulvar neoplasia: an opportunity for treatment with black raspberry extractAmy S Joehlin-Price, Camille T Elkins, Julie A Stephens, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Gynecologic Oncology|March 5, 2017
The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendationsDavid E Cohn, Emily Ko, Larissa A Meyer, et al.
Gynecologic Oncology|June 30, 2009
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, David M O'Malley, et al.
Gynecologic Oncology|September 8, 2007
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterusAaron H Wolfson, Mark F Brady, Thomas Rocereto, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2015
Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative ComplicationsFloor J Backes, Maggie Rosen, Margaret Liang, et al.
Pageof 31